These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8401368

  • 1. Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemia.
    Chap L, Schiller G, Nimer SD.
    Bone Marrow Transplant; 1993 Aug; 12(2):173-5. PubMed ID: 8401368
    [Abstract] [Full Text] [Related]

  • 2. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Aug; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L, Díaz MA, Ortega JJ, Olive T, Martínez A, Badell I, Muñoz A, Gómez P.
    Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
    [Abstract] [Full Text] [Related]

  • 4. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 5. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL.
    Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
    Klingemann HG, Wilkie-Boyd K, Rubin A, Onetto N, Nantel SH, Barnett MJ, Reece DE, Shepherd JD, Phillips GL.
    Biotechnol Ther; 1994 Mar; 5(1-2):1-13. PubMed ID: 7703829
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Dugan MJ, Rouch DA, Akard LP, Sperl BG, Black JR, Markham RE, Jansen J.
    Bone Marrow Transplant; 1993 Oct; 12(4):417-419. PubMed ID: 8275044
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor.
    Bunin N, Leahey A, Kamani N, August C.
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374
    [Abstract] [Full Text] [Related]

  • 15. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
    Catalano L, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B.
    Haematologica; 1997 Feb; 82(1):71-2. PubMed ID: 9107088
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH, Christiansen NP, Fay JP, Brown R, Herzig R, Frankel S, Blumenson L, Herzig GP.
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Oct; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 18. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: double-blind placebo controlled trial.
    Powles R, Treleaven J, Millar J, Gordon-Smith EC, Tiley C, Findlay M, Teo C, Duncombe A, Robinson G.
    Bone Marrow Transplant; 1991 Oct; 7 Suppl 2():85-6. PubMed ID: 1878735
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.